HIV :: Abbott’s HIV-1 Viral Load Test Approved by FDA for Use on New m2000 Molecular Diagnostics Instrument
Abbott (NYSE: ABT) and Celera (NYSE:CRA), an Applera Corporation business, announced that Abbott has received U.S. Food and Drug Administration (FDA) approval to market the Abbott RealTime HIV-1 viral load test for use on the company?s m2000? automated instrument system.